Effects of glutamine in critical illness

Basit Öğe Kaydı
dc.contributor.authorCander, B
dc.contributor.authorKalkan, E
dc.contributor.authorKaymakci, A
dc.contributor.authorKoylu, R
dc.contributor.authorVatansev, H
dc.contributor.authorBulun, E
dc.date.accessioned2020-03-26T16:57:02Z
dc.date.available2020-03-26T16:57:02Z
dc.date.issued2005
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjectives: Under normal physiological conditions, glutamine is synthesized in large amounts by the human body and is considered nonessential. It has been hypothesized that glutamine may become a conditionally essential amino acid in patients with catabolic disease. The objective of this study is to investigate the prognostic effect of glutamine. Methods: Fort this study, we selected 48 patients from the intensive care unit. Group I consisted of 33 patients whose treatment included glutamine. We placed the remaining 15 patients in group 11, and they did not receive glutamine in their treatment. We retrospectively investigated treatment time, leucocyte levels and outcome. We carried out the study between January 2002 and January 2003 in Konya Governmental Hospital, Turkey. Results: The average duration of hospital stay in the glutamine group was 8 +/- 1.2 days, 58% of them leaving hospital with surrogate. However, in the group whose treatment did not include glutamine, 42% of them left the hospital surrogate, their average hospital stay being 12 3 days. In the group receiving glutamine in the treatment, there was a prominent decrease in leukocyte levels compared to the other group, and hospitalization times were shorter but there was no statistically significant difference in mortality or survival rates. Conclusions: Glutamine may decrease the catabolism. it may also have a positive effect on treatment time and the consequences of therapy in critically ill patients.en_US
dc.description.provenanceMade available in DSpace on 2020-03-26T16:57:02Z (GMT). No. of bitstreams: 0 Previous issue date: 2005en
dc.identifier.endpage973en_US
dc.identifier.issn0379-5284en_US
dc.identifier.issue6en_US
dc.identifier.pmid15983685en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage969en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/19702
dc.identifier.volume26en_US
dc.identifier.wosWOS:000231007600013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSAUDI MED Jen_US
dc.relation.ispartofSAUDI MEDICAL JOURNALen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleEffects of glutamine in critical illnessen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu